Sei Investments Co. Sells 72,889 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Sei Investments Co. decreased its position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 25.1% during the second quarter, HoldingsChannel reports. The firm owned 217,161 shares of the company’s stock after selling 72,889 shares during the quarter. Sei Investments Co.’s holdings in Acadia Healthcare were worth $14,668,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also modified their holdings of the company. Rhenman & Partners Asset Management AB acquired a new position in Acadia Healthcare during the 4th quarter worth $1,448,000. Harbor Capital Advisors Inc. acquired a new position in shares of Acadia Healthcare during the 2nd quarter worth about $800,000. TCW Group Inc. boosted its stake in Acadia Healthcare by 63.8% during the 2nd quarter. TCW Group Inc. now owns 62,888 shares of the company’s stock valued at $4,247,000 after purchasing an additional 24,487 shares during the period. Axiom Investors LLC DE grew its holdings in Acadia Healthcare by 349.0% in the 4th quarter. Axiom Investors LLC DE now owns 68,380 shares of the company’s stock valued at $5,317,000 after buying an additional 53,150 shares during the last quarter. Finally, SG Americas Securities LLC increased its position in Acadia Healthcare by 435.6% in the 2nd quarter. SG Americas Securities LLC now owns 18,227 shares of the company’s stock worth $1,231,000 after buying an additional 14,824 shares during the period.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on ACHC shares. Cantor Fitzgerald reissued a “neutral” rating and issued a $90.00 price objective on shares of Acadia Healthcare in a research report on Monday, August 19th. Royal Bank of Canada reissued an “outperform” rating and issued a $94.00 price target on shares of Acadia Healthcare in a report on Friday, September 20th. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of Acadia Healthcare from $70.00 to $75.00 and gave the stock a “hold” rating in a report on Friday, August 2nd. Finally, Barclays reduced their target price on shares of Acadia Healthcare from $89.00 to $83.00 and set an “overweight” rating for the company in a research note on Thursday, August 1st. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and six have given a buy rating to the company. Based on data from MarketBeat, Acadia Healthcare presently has a consensus rating of “Moderate Buy” and a consensus target price of $87.44.

Acadia Healthcare Trading Down 0.1 %

Shares of ACHC opened at $75.66 on Friday. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 0.60. The stock has a market cap of $7.02 billion, a PE ratio of -540.43, a PEG ratio of 2.19 and a beta of 1.30. Acadia Healthcare Company, Inc. has a 1 year low of $62.04 and a 1 year high of $87.77. The stock has a 50 day simple moving average of $74.26 and a 200-day simple moving average of $71.84.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings data on Wednesday, July 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.87 by $0.04. Acadia Healthcare had a positive return on equity of 11.42% and a negative net margin of 0.17%. The firm had revenue of $796.00 million during the quarter, compared to analyst estimates of $784.38 million. During the same period in the prior year, the company posted $0.92 earnings per share. The business’s revenue for the quarter was up 8.8% compared to the same quarter last year. On average, sell-side analysts predict that Acadia Healthcare Company, Inc. will post 3.51 EPS for the current fiscal year.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.